Old Mission Capital LLC Vertex Pharmaceuticals Inc Transaction History

Old Mission Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $4.31 Million - $5.37 Million	-18,360 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $4.07 Million - $4.79 Million	18,360 New	18,360 $4.79 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $823,339 - $961,993	-5,431 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $745,567 - $844,792	5,431	5,431 $814,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.